- Home
- KFFB vs ATHA Comparison
KFFB vs ATHA Comparison
Compare KFFB & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFFB
- ATHA
- Stock Information
- Founded
- KFFB 2005
- ATHA 2011
- Country
- KFFB United States
- ATHA United States
- Employees
- KFFB N/A
- ATHA N/A
- Industry
- KFFB Savings Institutions
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- KFFB Finance
- ATHA Health Care
- Exchange
- KFFB Nasdaq
- ATHA Nasdaq
- Market Cap
- KFFB 21.0M
- ATHA 21.0M
- IPO Year
- KFFB 2005
- ATHA 2020
- Fundamental
- Price
- KFFB $2.54
- ATHA $0.26
- Analyst Decision
- KFFB
- ATHA Buy
- Analyst Count
- KFFB 0
- ATHA 4
- Target Price
- KFFB N/A
- ATHA $11.25
- AVG Volume (30 Days)
- KFFB 3.7K
- ATHA 214.5K
- Earning Date
- KFFB 05-12-2025
- ATHA 05-09-2025
- Dividend Yield
- KFFB N/A
- ATHA N/A
- EPS Growth
- KFFB N/A
- ATHA N/A
- EPS
- KFFB N/A
- ATHA N/A
- Revenue
- KFFB $8,308,000.00
- ATHA N/A
- Revenue This Year
- KFFB N/A
- ATHA N/A
- Revenue Next Year
- KFFB N/A
- ATHA N/A
- P/E Ratio
- KFFB N/A
- ATHA N/A
- Revenue Growth
- KFFB 13.79
- ATHA N/A
- 52 Week Low
- KFFB $2.00
- ATHA $0.22
- 52 Week High
- KFFB $3.72
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- KFFB 46.45
- ATHA 45.40
- Support Level
- KFFB $1.96
- ATHA $0.23
- Resistance Level
- KFFB $2.75
- ATHA $0.30
- Average True Range (ATR)
- KFFB 0.16
- ATHA 0.03
- MACD
- KFFB -0.00
- ATHA 0.00
- Stochastic Oscillator
- KFFB 73.42
- ATHA 37.12
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.